Page 33 - Amgen News Today

In Amgen Inc. v. Sanofi,1 the Supreme Court unanimously held that "[i]f a patent claims an entire class of processes, machines, manufactures, or compositions of matter...

In Amgen Inc. v. Sanofi,1 the Supreme Court unanimously held that [i]f a patent claims an entire class of processes, machines, manufactures, or compositions of matter, the patent specification must...

ETFs are very passive investments.

GHS Receives 1,510 Vails of Rituximab to Support the Treatment of Cancer

While Novo Nordisk and Eli Lilly have soared in the past year, Roundhill Investments sees bigger gains ahead for the GLP-1 drugmakers.

While Novo Nordisk and Eli Lilly have soared in the past year, Roundhill Investments sees bigger gains ahead for the GLP-1 drugmakers.

GHS Receives Medication For Childhood Cancer Treatment

As the era of biologics and biosimilar litigations heats up in the United States, Europe's Unified Patent Court (UPC) is also taking center stage with the first two biosimilar disputes filed in March and April.

The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, reaching a staggering...

The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, reaching a staggering...